CNBC Television published this video item, entitled “Jim Cramer weighs in on Johnson & Johnson’s Covid vaccine trial results” – below is their description.
Johnson & Johnson said Friday its single-dose coronavirus vaccine was 66% effective overall in protecting against Covid-19. The vaccine, however, appeared to be less potent against other variants. CNBC’s Jim Cramer weighs in.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.